Association of polymorphisms of the transforming growth factor-β1 gene with the rate of progression of HCV-induced liver fibrosis

被引:90
作者
Gewaltig, J
Mangasser-Stephan, K
Gartung, C
Biesterfeld, S
Gressner, AM
机构
[1] RWTH Univ Hosp Aachen, Cent Lab, Inst Clin Chem & Pathobiochem, D-52074 Aachen, Germany
[2] RWTH Univ Hosp, Dept Internal Med 3, Aachen, Germany
[3] RWTH Univ Hosp, Inst Pathol, Aachen, Germany
关键词
ARMS-PCR; METAVIR-score; genotyping; TGF-beta; 1; polymorphisms; fibrosis; cytokine;
D O I
10.1016/S0009-8981(01)00738-0
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: The objective of the present study was to elucidate possible relationships between four polymorphisms of the TGF-beta1 gene ( - 800G > A; - 509C>T; Leu10Pro; Arg25Pro) and stage, histological activity grade and progression rate of liver fibrosis, classified according to the METAVIR-score. Methods: Three study groups, i.e. 48 patients with hepatic fibrosis (26 with known duration of hepatitis C virus infection), 47 patients with non-fibrotic diseases and 50 healthy blood donors, were analyzed for TGF-beta1 polymorphisms using ARMS-PCR and sequence analysis. The concentrations of total TGF-beta1 in plasma and of hyaluronan, P-III-NP and activities of transminases in serum were measured. Results: The presence of proline at codons 10 and/or 25 was associated with a faster progression of fibrosis than other polymorphisms. Patients with the genotype (25)ArgPro developed fibrosis significantly faster (0.23 units/year) than those having (25)ArgArg (0.08 units/year). Similarly, the fibrosis progression rate of patients with genotypes (10)LeuPro and (10)ProPro was almost three times as fast as of those having genotype (10)LeuLeu. Stage and histological activity grade of fibrosis in (25)ArgPro in comparison to (25)ArgArg were higher. Also (10)LeuPro showed a higher average stage of fibrosis than (10)LeuLeu. The TGF-beta1 plasma concentrations of patients with hepatic fibrosis were not significantly different between carriers of (25)ArgArg and (25)ArgPro genotypes. The frequency of the genotype (25)ArgPro in liver fibrotic patients was about three times that of the control group whereas the frequency distribution of the genotype 25ArgArg tended to lower frequency in the fibrosis group. TGF-beta1-promoter polymorphisms did not show any correlation with stage, grade or progression of liver fibrosis. Conclusion: Our results indicate that the heterozygous ArgPro of codon 25 predicts significantly faster fibrotic progression of chronic hepatitis C than the homozygous (25)ArgArg genotype. The homozygous LeuLeu genotype of codon 10 showed a slow progression of fibrosis. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:83 / 94
页数:12
相关论文
共 54 条
[1]   TRANSFORMING GROWTH-FACTOR-BETA AS A PREDICTOR OF LIVER AND LUNG FIBROSIS AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ADVANCED BREAST-CANCER [J].
ANSCHER, MS ;
PETERS, WP ;
REISENBICHLER, H ;
PETROS, WP ;
JIRTLE, RL .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (22) :1592-1598
[2]   TGF-β1 genotype and accelerated decline in lung function of patients with cystic fibrosis [J].
Arkwright, PD ;
Laurie, S ;
Super, M ;
Pravica, V ;
Schwarz, MJ ;
Webb, AK ;
Hutchinson, IV .
THORAX, 2000, 55 (06) :459-462
[3]  
ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155
[4]   TYPE-BETA TRANSFORMING GROWTH-FACTOR IN HUMAN-PLATELETS - RELEASE DURING PLATELET DEGRANULATION AND ACTION ON VASCULAR SMOOTH-MUSCLE CELLS [J].
ASSOIAN, RK ;
SPORN, MB .
JOURNAL OF CELL BIOLOGY, 1986, 102 (04) :1217-1223
[5]   Genotypic variation in the transforming growth factor-β1 gene -: Association with transforming growth factor-pi production, fibrotic lung disease, and graft fibrosis after lung transplantation [J].
Awad, MR ;
El-Gamel, A ;
Hasleton, P ;
Turner, DM ;
Sinnott, PJ ;
Hutchinson, IV .
TRANSPLANTATION, 1998, 66 (08) :1014-1020
[6]   ACTIVATION OF RAT-LIVER PERISINUSOIDAL LIPOCYTES BY TRANSFORMING GROWTH-FACTORS DERIVED FROM MYOFIBROBLASTLIKE CELLS - A POTENTIAL MECHANISM OF SELF PERPETUATION IN LIVER FIBROGENESIS [J].
BACHEM, MG ;
MEYER, D ;
MELCHIOR, R ;
SELL, KM ;
GRESSNER, AM .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (01) :19-27
[7]   An algorithm for the grading of activity in chronic hepatitis C [J].
Bedossa, P ;
Poynard, T .
HEPATOLOGY, 1996, 24 (02) :289-293
[8]  
BEDOSSA P, 1994, HEPATOLOGY, V20, P15
[9]  
BEDOSSA P, 1995, J HEPATOL, V22, P37
[10]   Mechanisms of disease:: Role of transforming growth factor β in human disease. [J].
Blobe, GC ;
Schiemann, WP ;
Lodish, HF .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) :1350-1358